These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25783680

  • 21. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M, Crippa S, Domínguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P.
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [Abstract] [Full Text] [Related]

  • 22. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of the lymph node ratio after resection of periampullary carcinomas.
    Farid SG, Falk GA, Joyce D, Chalikonda S, Walsh RM, Smith AM, Morris-Stiff G.
    HPB (Oxford); 2014 Jun; 16(6):582-91. PubMed ID: 23777362
    [Abstract] [Full Text] [Related]

  • 24. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP.
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [Abstract] [Full Text] [Related]

  • 25. Validation of the eighth edition of the American Joint Committee on Cancer staging system for ampulla of Vater cancer.
    Kim SJ, An S, Kang HJ, Kim JY, Jang MA, Lee JH, Song KB, Hwang DW, Cho H, Kim SC, Yu E, Hong SM.
    Surgery; 2018 May; 163(5):1071-1079. PubMed ID: 29452703
    [Abstract] [Full Text] [Related]

  • 26. Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience.
    Demirci NS, Cavdar E, Ozdemir NY, Yuksel S, Iriagac Y, Erdem GU, Odabas H, Hacibekiroglu I, Karaagac M, Ucar M, Ozturk B, Bozkaya Y.
    Medicina (Kaunas); 2024 May 16; 60(5):. PubMed ID: 38793001
    [Abstract] [Full Text] [Related]

  • 27. Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.
    Feretis M, Wang T, Iype S, Duckworth A, Brais R, Basu B, Jamieson NV, Huguet E, Balakrishnan A, Jah A, Praseedom RK, Harper SJ, Liau SS.
    Pancreas; 2017 May 16; 46(10):1314-1321. PubMed ID: 28902764
    [Abstract] [Full Text] [Related]

  • 28. Survival and prognostic factors in pancreatic and ampullary cancer.
    Lemke J, Schäfer D, Sander S, Henne-Bruns D, Kornmann M.
    Anticancer Res; 2014 Jun 16; 34(6):3011-20. PubMed ID: 24922667
    [Abstract] [Full Text] [Related]

  • 29. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ, Viganò L, Russolillo N, Langella S, Ferrero A, Capussotti L.
    Ann Surg Oncol; 2015 Mar 16; 22(3):811-8. PubMed ID: 25201500
    [Abstract] [Full Text] [Related]

  • 30. Extracapsular lymph node spread as a negative prognostic factor of adenocarcinoma of the pancreas and cancer of the papilla of vater.
    Prenzel KL, Hölscher AH, Drebber U, Bollschweiler E, Gutschow CA, Stippel DL, Mönig SP.
    Pancreas; 2014 Jan 16; 43(1):64-8. PubMed ID: 24212239
    [Abstract] [Full Text] [Related]

  • 31. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
    Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M.
    Ann Surg Oncol; 2010 Apr 16; 17(4):991-7. PubMed ID: 20108122
    [Abstract] [Full Text] [Related]

  • 32. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
    Khan AW, Dhillon AP, Hutchins R, Abraham A, Shah SR, Snooks S, Davidson BR.
    Eur J Surg Oncol; 2002 Sep 16; 28(6):637-44. PubMed ID: 12359201
    [Abstract] [Full Text] [Related]

  • 33. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.
    Tesarikova J, Skalicky P, Kurfurstova D, Svebisova H, Urban O, Falt P, Zapletalova J, Klos D, Lovecek M.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep 16; 166(3):290-296. PubMed ID: 34012147
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
    Vilhordo DW, Gregório C, Valentini DF, Edelweiss MIA, Uchoa DM, Osvaldt AB.
    J Gastrointest Cancer; 2021 Sep 16; 52(3):872-881. PubMed ID: 32808236
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma.
    Sakata J, Shirai Y, Wakai T, Yokoyama N, Sakata E, Akazawa K, Hatakeyama K.
    Eur J Surg Oncol; 2007 Apr 16; 33(3):346-51. PubMed ID: 17097846
    [Abstract] [Full Text] [Related]

  • 40. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
    Adsay V, Ohike N, Tajiri T, Kim GE, Krasinskas A, Balci S, Bagci P, Basturk O, Bandyopadhyay S, Jang KT, Kooby DA, Maithel SK, Sarmiento J, Staley CA, Gonzalez RS, Kong SY, Goodman M.
    Am J Surg Pathol; 2012 Nov 16; 36(11):1592-608. PubMed ID: 23026934
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.